Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46)

Browse all the diagnosis codes used for poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (t46). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.

Clinical Information

Calcium Channel Blockers - A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Hyperkalemia - Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Pseudohypoaldosteronism - A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.

Instructional Notations

Type 1 Excludes

A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

  • poisoning by, adverse effect of and underdosing of metaraminol T44.4

7th Character Note

Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

  • The appropriate 7th character is to be added to each code from category T46

7th Character

Indicates that a seventh character is to be assigned to codes in a subcategory.

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela
  • Injury, poisoning and certain other consequences of external causes (S00–T88)

    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)

        • Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system (T46)

        • T46 Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
        • T46.0 Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
        • T46.0X Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
        • T46.0X1 Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
        • T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
        • T46.0X1D Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
        • T46.0X1S Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
        • T46.0X2 Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
        • T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
        • T46.0X2D Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
        • T46.0X2S Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
        • T46.0X3 Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
        • T46.0X3A Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
        • T46.0X3D Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
        • T46.0X3S Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
        • T46.0X4 Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
        • T46.0X4A Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
        • T46.0X4D Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
        • T46.0X4S Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
        • T46.0X5 Adverse effect of cardiac-stimulant glycosides and drugs of similar action
        • T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
        • T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
        • T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
        • T46.0X6 Underdosing of cardiac-stimulant glycosides and drugs of similar action
        • T46.0X6A Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
        • T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
        • T46.0X6S Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
        • T46.1 Poisoning by, adverse effect of and underdosing of calcium-channel blockers
        • T46.1X Poisoning by, adverse effect of and underdosing of calcium-channel blockers
        • T46.1X1 Poisoning by calcium-channel blockers, accidental (unintentional)
        • T46.1X1A Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
        • T46.1X1D Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
        • T46.1X1S Poisoning by calcium-channel blockers, accidental (unintentional), sequela
        • T46.1X2 Poisoning by calcium-channel blockers, intentional self-harm
        • T46.1X2A Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
        • T46.1X2D Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
        • T46.1X2S Poisoning by calcium-channel blockers, intentional self-harm, sequela
        • T46.1X3 Poisoning by calcium-channel blockers, assault
        • T46.1X3A Poisoning by calcium-channel blockers, assault, initial encounter
        • T46.1X3D Poisoning by calcium-channel blockers, assault, subsequent encounter
        • T46.1X3S Poisoning by calcium-channel blockers, assault, sequela
        • T46.1X4 Poisoning by calcium-channel blockers, undetermined
        • T46.1X4A Poisoning by calcium-channel blockers, undetermined, initial encounter
        • T46.1X4D Poisoning by calcium-channel blockers, undetermined, subsequent encounter
        • T46.1X4S Poisoning by calcium-channel blockers, undetermined, sequela
        • T46.1X5 Adverse effect of calcium-channel blockers
        • T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
        • T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter
        • T46.1X5S Adverse effect of calcium-channel blockers, sequela
        • T46.1X6 Underdosing of calcium-channel blockers
        • T46.1X6A Underdosing of calcium-channel blockers, initial encounter
        • T46.1X6D Underdosing of calcium-channel blockers, subsequent encounter
        • T46.1X6S Underdosing of calcium-channel blockers, sequela
        • T46.2 Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
        • T46.2X Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
        • T46.2X1 Poisoning by other antidysrhythmic drugs, accidental (unintentional)
        • T46.2X1A Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
        • T46.2X1D Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
        • T46.2X1S Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
        • T46.2X2 Poisoning by other antidysrhythmic drugs, intentional self-harm
        • T46.2X2A Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
        • T46.2X2D Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
        • T46.2X2S Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
        • T46.2X3 Poisoning by other antidysrhythmic drugs, assault
        • T46.2X3A Poisoning by other antidysrhythmic drugs, assault, initial encounter
        • T46.2X3D Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
        • T46.2X3S Poisoning by other antidysrhythmic drugs, assault, sequela
        • T46.2X4 Poisoning by other antidysrhythmic drugs, undetermined
        • T46.2X4A Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
        • T46.2X4D Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
        • T46.2X4S Poisoning by other antidysrhythmic drugs, undetermined, sequela
        • T46.2X5 Adverse effect of other antidysrhythmic drugs
        • T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
        • T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter
        • T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
        • T46.2X6 Underdosing of other antidysrhythmic drugs
        • T46.2X6A Underdosing of other antidysrhythmic drugs, initial encounter
        • T46.2X6D Underdosing of other antidysrhythmic drugs, subsequent encounter
        • T46.2X6S Underdosing of other antidysrhythmic drugs, sequela
        • T46.3 Poisoning by, adverse effect of and underdosing of coronary vasodilators
        • T46.3X Poisoning by, adverse effect of and underdosing of coronary vasodilators
        • T46.3X1 Poisoning by coronary vasodilators, accidental (unintentional)
        • T46.3X1A Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
        • T46.3X1D Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
        • T46.3X1S Poisoning by coronary vasodilators, accidental (unintentional), sequela
        • T46.3X2 Poisoning by coronary vasodilators, intentional self-harm
        • T46.3X2A Poisoning by coronary vasodilators, intentional self-harm, initial encounter
        • T46.3X2D Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
        • T46.3X2S Poisoning by coronary vasodilators, intentional self-harm, sequela
        • T46.3X3 Poisoning by coronary vasodilators, assault
        • T46.3X3A Poisoning by coronary vasodilators, assault, initial encounter
        • T46.3X3D Poisoning by coronary vasodilators, assault, subsequent encounter
        • T46.3X3S Poisoning by coronary vasodilators, assault, sequela
        • T46.3X4 Poisoning by coronary vasodilators, undetermined
        • T46.3X4A Poisoning by coronary vasodilators, undetermined, initial encounter
        • T46.3X4D Poisoning by coronary vasodilators, undetermined, subsequent encounter
        • T46.3X4S Poisoning by coronary vasodilators, undetermined, sequela
        • T46.3X5 Adverse effect of coronary vasodilators
        • T46.3X5A Adverse effect of coronary vasodilators, initial encounter
        • T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter
        • T46.3X5S Adverse effect of coronary vasodilators, sequela
        • T46.3X6 Underdosing of coronary vasodilators
        • T46.3X6A Underdosing of coronary vasodilators, initial encounter
        • T46.3X6D Underdosing of coronary vasodilators, subsequent encounter
        • T46.3X6S Underdosing of coronary vasodilators, sequela
        • T46.4 Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
        • T46.4X Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
        • T46.4X1 Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
        • T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
        • T46.4X1D Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
        • T46.4X1S Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
        • T46.4X2 Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
        • T46.4X2A Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
        • T46.4X2D Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
        • T46.4X2S Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
        • T46.4X3 Poisoning by angiotensin-converting-enzyme inhibitors, assault
        • T46.4X3A Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
        • T46.4X3D Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
        • T46.4X3S Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
        • T46.4X4 Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
        • T46.4X4A Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
        • T46.4X4D Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
        • T46.4X4S Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
        • T46.4X5 Adverse effect of angiotensin-converting-enzyme inhibitors
        • T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
        • T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
        • T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
        • T46.4X6 Underdosing of angiotensin-converting-enzyme inhibitors
        • T46.4X6A Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
        • T46.4X6D Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
        • T46.4X6S Underdosing of angiotensin-converting-enzyme inhibitors, sequela
        • T46.5 Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
        • T46.5X Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
        • T46.5X1 Poisoning by other antihypertensive drugs, accidental (unintentional)
        • T46.5X1A Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
        • T46.5X1D Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
        • T46.5X1S Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
        • T46.5X2 Poisoning by other antihypertensive drugs, intentional self-harm
        • T46.5X2A Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
        • T46.5X2D Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
        • T46.5X2S Poisoning by other antihypertensive drugs, intentional self-harm, sequela
        • T46.5X3 Poisoning by other antihypertensive drugs, assault
        • T46.5X3A Poisoning by other antihypertensive drugs, assault, initial encounter
        • T46.5X3D Poisoning by other antihypertensive drugs, assault, subsequent encounter
        • T46.5X3S Poisoning by other antihypertensive drugs, assault, sequela
        • T46.5X4 Poisoning by other antihypertensive drugs, undetermined
        • T46.5X4A Poisoning by other antihypertensive drugs, undetermined, initial encounter
        • T46.5X4D Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
        • T46.5X4S Poisoning by other antihypertensive drugs, undetermined, sequela
        • T46.5X5 Adverse effect of other antihypertensive drugs
        • T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter
        • T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter
        • T46.5X5S Adverse effect of other antihypertensive drugs, sequela
        • T46.5X6 Underdosing of other antihypertensive drugs
        • T46.5X6A Underdosing of other antihypertensive drugs, initial encounter
        • T46.5X6D Underdosing of other antihypertensive drugs, subsequent encounter
        • T46.5X6S Underdosing of other antihypertensive drugs, sequela
        • T46.6 Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
        • T46.6X Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
        • T46.6X1 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
        • T46.6X1A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
        • T46.6X1D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
        • T46.6X1S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
        • T46.6X2 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
        • T46.6X2A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
        • T46.6X2D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
        • T46.6X2S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
        • T46.6X3 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
        • T46.6X3A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
        • T46.6X3D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
        • T46.6X3S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
        • T46.6X4 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
        • T46.6X4A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
        • T46.6X4D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
        • T46.6X4S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
        • T46.6X5 Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
        • T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
        • T46.6X5D Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
        • T46.6X5S Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
        • T46.6X6 Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
        • T46.6X6A Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
        • T46.6X6D Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
        • T46.6X6S Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
        • T46.7 Poisoning by, adverse effect of and underdosing of peripheral vasodilators
        • T46.7X Poisoning by, adverse effect of and underdosing of peripheral vasodilators
        • T46.7X1 Poisoning by peripheral vasodilators, accidental (unintentional)
        • T46.7X1A Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
        • T46.7X1D Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
        • T46.7X1S Poisoning by peripheral vasodilators, accidental (unintentional), sequela
        • T46.7X2 Poisoning by peripheral vasodilators, intentional self-harm
        • T46.7X2A Poisoning by peripheral vasodilators, intentional self-harm, initial encounter
        • T46.7X2D Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
        • T46.7X2S Poisoning by peripheral vasodilators, intentional self-harm, sequela
        • T46.7X3 Poisoning by peripheral vasodilators, assault
        • T46.7X3A Poisoning by peripheral vasodilators, assault, initial encounter
        • T46.7X3D Poisoning by peripheral vasodilators, assault, subsequent encounter
        • T46.7X3S Poisoning by peripheral vasodilators, assault, sequela
        • T46.7X4 Poisoning by peripheral vasodilators, undetermined
        • T46.7X4A Poisoning by peripheral vasodilators, undetermined, initial encounter
        • T46.7X4D Poisoning by peripheral vasodilators, undetermined, subsequent encounter
        • T46.7X4S Poisoning by peripheral vasodilators, undetermined, sequela
        • T46.7X5 Adverse effect of peripheral vasodilators
        • T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
        • T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter
        • T46.7X5S Adverse effect of peripheral vasodilators, sequela
        • T46.7X6 Underdosing of peripheral vasodilators
        • T46.7X6A Underdosing of peripheral vasodilators, initial encounter
        • T46.7X6D Underdosing of peripheral vasodilators, subsequent encounter
        • T46.7X6S Underdosing of peripheral vasodilators, sequela
        • T46.8 Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
        • T46.8X Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
        • T46.8X1 Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
        • T46.8X1A Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
        • T46.8X1D Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
        • T46.8X1S Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
        • T46.8X2 Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
        • T46.8X2A Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
        • T46.8X2D Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
        • T46.8X2S Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
        • T46.8X3 Poisoning by antivaricose drugs, including sclerosing agents, assault
        • T46.8X3A Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
        • T46.8X3D Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
        • T46.8X3S Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
        • T46.8X4 Poisoning by antivaricose drugs, including sclerosing agents, undetermined
        • T46.8X4A Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
        • T46.8X4D Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
        • T46.8X4S Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
        • T46.8X5 Adverse effect of antivaricose drugs, including sclerosing agents
        • T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
        • T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
        • T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela
        • T46.8X6 Underdosing of antivaricose drugs, including sclerosing agents
        • T46.8X6A Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
        • T46.8X6D Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
        • T46.8X6S Underdosing of antivaricose drugs, including sclerosing agents, sequela
        • T46.9 Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
        • T46.90 Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
        • T46.901 Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
        • T46.901A Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
        • T46.901D Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
        • T46.901S Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
        • T46.902 Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
        • T46.902A Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
        • T46.902D Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
        • T46.902S Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
        • T46.903 Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
        • T46.903A Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
        • T46.903D Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
        • T46.903S Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
        • T46.904 Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
        • T46.904A Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
        • T46.904D Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
        • T46.904S Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
        • T46.905 Adverse effect of unspecified agents primarily affecting the cardiovascular system
        • T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
        • T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
        • T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
        • T46.906 Underdosing of unspecified agents primarily affecting the cardiovascular system
        • T46.906A Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
        • T46.906D Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
        • T46.906S Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
        • T46.99 Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
        • T46.991 Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
        • T46.991A Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
        • T46.991D Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
        • T46.991S Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
        • T46.992 Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
        • T46.992A Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
        • T46.992D Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
        • T46.992S Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
        • T46.993 Poisoning by other agents primarily affecting the cardiovascular system, assault
        • T46.993A Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
        • T46.993D Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
        • T46.993S Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
        • T46.994 Poisoning by other agents primarily affecting the cardiovascular system, undetermined
        • T46.994A Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
        • T46.994D Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
        • T46.994S Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
        • T46.995 Adverse effect of other agents primarily affecting the cardiovascular system
        • T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
        • T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
        • T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela
        • T46.996 Underdosing of other agents primarily affecting the cardiovascular system
        • T46.996A Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
        • T46.996D Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
        • T46.996S Underdosing of other agents primarily affecting the cardiovascular system, sequela